Oxford Gene Technology
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, arrays and FISH reflects our commitment to improving the future of genetic clinical care.
Latest Content
Product News
OGT Expands MRD Detection Capabilities With New SureSeq Myeloid MRD Plus NGS Panel
OGT launches the SureSeq Myeloid MRD Plus Panel, enabling ultra-sensitive MRD detection in AML with variant calls down to 0.01%.
Product News
US Food and Drug Administration Authorizes CytoCell KMT2A Breakapart FISH Probe Kit PDx
FDA clears OGT’s CytoCell KMT2A probe as a companion diagnostic for Revuforj in relapsed or refractory acute leukaemia.
Product News
OGT Unveils the Enhanced SureSeq CLL + CNV V3 Panel for Deeper Insights Into CLL Progression
Improving upon existing SureSeq technology, this latest SureSeq NGS panel unlocks more efficient and expansive genetic profiling for CLL samples.
Advertisement
